March 18, 2017 4:50 am JST

Omron subsidiary to invest in US medical device company

Duo eyes monitor for blood pressure, heart rate

OSAKA -- Omron Healthcare, a medical equipment subsidiary of Japanese electronics maker Omron, said Friday that it will invest $25 million in U.S. medical device venture AliveCor.

The equity stake Omron Healthcare will gain was not disclosed, but it is unlikely to exceed 30%.

AliveCor markets wearable heart rate monitors and a phone app to record results. Omron aims to use its investment to develop new products by combining AliveCor's heart rate monitors with its own blood pressure devices. The duo will jointly develop a blood pressure-heart rate monitor as well as services to prevent heart disease.

In addition to marketing heart monitors, AliveCor provides remote medical services by sending data taken from its devices directly to the patient's doctor.

Omron will use its network to expand sales of AliveCor products in Europe and elewhere. 

(Nikkei)

OMRON Corp.

Japan

Market(Ticker): TKS(6645)
Sector:
Industry:
Electronic Technology
Electronic Equipment/Instruments
Market cap(USD): 9,305.87M
Shares: 213.95M

Get Insights on Asia In Your Inbox

To read the full story, Subscribe or Log in

Get your first month for $0.99

Redeemable only through the Subscribe button below

Once subscribed, you can…

  • Read all stories with unlimited access (5 articles per month without subscription)
  • Use our smartphone and tablet apps

To read the full story, Subscribe or Log in

3 months for $9
SUBSCRIBE TODAY

Take advantage of this limited offer.
Subscribe now to get unlimited access to all articles.

To read the full story, Update your account

We could not renew your subscription.
You need to update your payment information.

To read the full story, Subscribe or Log in

Once subscribed, you can…

  • Read all stories with unlimited access (5 articles per month without subscription)
  • Use our smartphone and tablet apps

To read the full story, Subscribe or Log in

3 months for $9
SUBSCRIBE TODAY

Take advantage of this limited offer.
Subscribe now to get unlimited access to all articles.

To read the full story, Update your account

We could not renew your subscription.
You need to update your payment information.